AdAlta and Baker IDI sign agreement to identify i-bodies to anti-thrombotic target
News & Media
AdAlta and Roche sign agreement to evaluate shark antibody technology
AdAlta receives VC investment from Perth-based Yuuwa Capital
AdAlta and Baker IDI sign agreement to identify i-bodies to anti-thrombotic target
AdAlta and Roche sign agreement to evaluate shark antibody technology
AdAlta receives VC investment from Perth-based Yuuwa Capital